Like ketoconazole treatment, Cyp51 knockout significantly suppressed CT26 tumor progression in the immunocompetent BALB/c mice (Fig. 6A,B), along with reduction of tumor-infiltrating Th17 population (Fig. 6C). The gene discussed is CYP51A1; the disease is neoplasm.